The pace of vaccinations in the U.S. is failing to meet expectations, in part due to inadequate production and supply. But President Biden is planning to invoke the federal Defense Production Act in an effort to ensure companies, manufacturers and states get what they need. Miles O’Brien reports on what some companies are already doing […]
Battered by COVID-19, but skeptical of vaccinations
In the race to get COVID vaccines out the door, public health experts have labored over who should receive vaccinations first. But they also hope to find solutions to deep-rooted unfairness laid bare by the virus, with Black, LatinX and indigenous people more likely than white individuals to get COVID-19. But reluctance and mistrust over […]
The risks and rewards of Operation Warp Speed’s approach to vaccines
The race to develop vaccine candidates to prevent COVID-19 represents an unprecedented national and global effort. President Trump and some public health experts say encouraging early results from Pfizer and Moderna suggest the approach is working. But there are also questions about the risks of ramping up vaccine research and development at this scale and […]
How a COVID vaccine might work — and the challenges of distributing it
As drug companies around the world rush to develop candidates for coronavirus vaccines, Pfizer announced encouraging early data from its own trials Monday. What do the preliminary results show, and even if they are borne out, what challenges remain with regard to production and distribution of the vaccine? Science correspondent Miles O’ Brien joins William […]
- 1
- 2
- 3
- …
- 17
- Next Page »